The 3rd European Hematology and Blood Disorders Congress, set in the vibrant city of London, UK, promises to be a pivotal event in 2026. Renowned experts and researchers will gather to explore cutting-edge advancements in hematology, from leukemia to lymphoma treatments, Immunohematology, Neuro-Hematology and delve into breakthroughs in blood disorders management. Attendees can anticipate insightful discussions on genetic therapies, immunotherapy innovations, and personalized medicine approaches, this congress will not only foster scientific exchange but also inspire new collaborations that could shape the future of hematology globally.

